Top upgrades and downgrades on 7/8: PYPL, UPST, AAL, RCKT and more

Analysts Notebook wrote a column · Jul 8, 2022 06:47

Upgrades

• $Vita Coco (COCO.US)$ : BofA Securities Upgrades to Buy from Neutral - PT $12 (from $10)

• $Diebold Nixdorf (DBD.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $5

• $Eversource Energy (ES.US)$ : Guggenheim Upgrades to Buy from Neutral - PT $97 (from $92)

• $Howmet Aerospace (HWM.US)$ : Benchmark Upgrades to Buy from Neutral - PT $40

• $The Interpublic Group of Companies (IPG.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $33 (from $40)

• $Lennox International (LII.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $260 (from $295)

• $Omnicom Group (OMC.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $73 (from $96)

• $Healthpeak Properties (PEAK.US)$ : Citigroup Upgrades to Buy from Neutral - PT $31 (from $33)

• $Trane Technologies (TT.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $180 (from $190)

• $XPO (XPO.US)$ : Morgan Stanley Upgrades to Overweight from Equalweight - PT $75

Downgrades

• $American Airlines (AAL.US)$ : Argus Downgrades to Hold from Buy

• $Audacy (AUD.US)$ : Wells Fargo Downgrades to Underweight from Overweight

• $Agilent Technologies (A.US)$ : Citigroup Downgrades to Neutral from Buy - PT $140 (from $175)

• $Illinois Tool Works (ITW.US)$ : UBS Downgrades to Neutral from Buy - PT $185 (from $243)

• $Madrigal Pharmaceuticals (MDGL.US)$ : B.Riley Downgrades to Neutral from Buy - PT $75 (from $131)

• $Peoples Bancorp (PEBO.US)$ : Piper Sandler Downgrades to Neutral from Overweight - PT $30 (from $31)

• $PayPal (PYPL.US)$ : Redburn Downgrades to Neutral from Buy

• $Six Flags Entertainment (SIX.US)$ : Citigroup Downgrades to Neutral from Buy - PT $26 (from $41)

• $Upstart (UPST.US)$ : JMP Securities Downgrades to Market Perform from Market Outperform

• $Meridian Bioscience (VIVO.US)$ : H.C. Wainwright Downgrades to Neutral from Buy - PT $34 (from $30)

Initiated

• $Blueprint Medicines (BPMC.US)$ : Oppenheimer initiates at Outperform - PT $80

• $CCC Intelligent Solutions Holdings (CCCS.US)$ : Jefferies initiates at Buy - PT $12

• $DNOW Inc (DNOW.US)$ : Benchmark initiates at Buy - PT $13

• $Immuneering (IMRX.US)$ : Chardan initiates at Buy - PT $18

• $MRC Global (MRC.US)$ : Benchmark initiates at Buy - PT $14

• $Rocket Pharmaceuticals (RCKT.US)$ : Raymond James initiates at Outperform - PT $22

• $Sitio Royalties (STR.US)$ : Barclays initiates at Overweight - PT $35

• $Vertex Energy (VTNR.US)$ : Oppenheimer initiates at Outperform - PT $18

• $DPCM Capital (XPOA.US)$ : Benchmark initiates at Buy - PT $14

Moomoo Inc. ("moomoo") provides mobile and online technology solutions for securities trading. Moomoo is not an investment adviser or a broker-dealer and it provides neither investment or financial advice nor securities trading services. All contents such as comments and links posted or shared by users of the community are opinions of the respective authors only and do not reflect the opinions, views, or positions of moomoo, its affiliates, or any employees of moomoo or its affiliates. Please consult a qualified investment or tax advisor for your personal financial planning and tax situations.

Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more

Translate

Report

527K Views

Comment

70037016 : anyone know what it. pays on royalty and when

Report
Reply

Cancel Reply

Analysts Notebook

Moomoo News Official Account

How do analysts evaluate the market?

18KFollowers

46Following

39KVisitors